Your browser doesn't support javascript.
loading
Serous retinal detachment after panretinal photocoagulation for proliferative diabetic retinopathy: a case report.
Schatz, Patrik; Aldayel, Ahmed; Taskintuna, Ibrahim; Abdelkader, Ehab; Mura, Marco.
Afiliación
  • Schatz P; Vitreoretinal Division, King Khaled Eye Specialist Hospital, Al-Oruba Street, PO Box 7191, Riyadh, 11462, Saudi Arabia. patrik.schatz@med.lu.se.
  • Aldayel A; Department of Ophthalmology, Clinical Sciences, Scane County University Hospital, University of Lund, Lund, Sweden. patrik.schatz@med.lu.se.
  • Taskintuna I; Vitreoretinal Division, King Khaled Eye Specialist Hospital, Al-Oruba Street, PO Box 7191, Riyadh, 11462, Saudi Arabia.
  • Abdelkader E; Vitreoretinal Division, King Khaled Eye Specialist Hospital, Al-Oruba Street, PO Box 7191, Riyadh, 11462, Saudi Arabia.
  • Mura M; Vitreoretinal Division, King Khaled Eye Specialist Hospital, Al-Oruba Street, PO Box 7191, Riyadh, 11462, Saudi Arabia.
J Med Case Rep ; 11(1): 265, 2017 Sep 19.
Article en En | MEDLINE | ID: mdl-28923115
BACKGROUND: Proliferative diabetic retinopathy is a major cause of visual impairment in working-age adults worldwide. Panretinal photocoagulation is a cornerstone in its management; however, it may include a range of side effects and complications, one of these being serous retinal detachment. To the best of our knowledge, this is the first report of the use of intravitreal injection of bevacizumab for serous retinal detachment after panretinal photocoagulation. CASE PRESENTATION: A 24-year-old Saudi man with poorly controlled type 1 diabetes presented with bilateral progressive proliferative retinopathy in spite of several sessions of panretinal photocoagulation. After one additional such session, he developed bilateral serous retinal detachment and vision loss, which was managed with a single bilateral intravitreal bevacizumab injection. The serous retinal detachment subsided with partial recovery of vision. CONCLUSIONS: Serous retinal detachment after panretinal photocoagulation for proliferative diabetic retinopathy is a rare complication nowadays. In this case, it seems that excessive photocoagulation exceeded the energy-absorbing capacity of the retinal pigment epithelium, leading to a disruption of the blood-retinal barrier. A single injection of bilateral intravitreal bevacizumab was sufficient to control the serous retinal detachment. This effect may have been due to a reduction of vascular leakage resulting from the mechanism of action of this drug. No complications were noted from the injection. Caution should be exerted when attempting bilateral panretinal photocoagulation.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Desprendimiento de Retina / Coagulación con Láser / Inhibidores de la Angiogénesis / Retinopatía Diabética / Bevacizumab Tipo de estudio: Etiology_studies Límite: Adult / Humans / Male Idioma: En Revista: J Med Case Rep Año: 2017 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Desprendimiento de Retina / Coagulación con Láser / Inhibidores de la Angiogénesis / Retinopatía Diabética / Bevacizumab Tipo de estudio: Etiology_studies Límite: Adult / Humans / Male Idioma: En Revista: J Med Case Rep Año: 2017 Tipo del documento: Article País de afiliación: Arabia Saudita Pais de publicación: Reino Unido